ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,503, issued on Dec. 2, was assigned to Sirna Therapeutics Inc. (Cambridge, Mass.).

"Short interfering nucleic acid (siNA) compositions" was invented by Brian Allen Carr (West Point, Pa.), Vasant R. Jadhav (Sharon, Mass.), Denise M. Kenski (San Francisco), David M. Tellers (West Point, Pa.) and Aarron T. Willingham (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity, and/or modulate a gene expression pathway. Specifically, the inventi...